Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration
- Citation:
- Annals of Oncology vol 28 (suppl_5) v605-v649
- Meeting Instance:
- ESMO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2805
- Pharmas:
- Grants:
- U10CA180821, U10CA180835, U10CA180882, U10CA180888, INCA, PHRC2009, EME 09/800/34, HTA 14/140/84, CRUK C1348/A15960, JFMC
- Corr. Author:
- Authors:
- Axel Grothey Alberto F. Sobrero Jeffrey A. Meyerhardt Takayuki Yoshino James Paul Julien Taieb Ioannis Sougklakos Rachel Kerr Roberto Labianca Anthony F. Shields Franck Bonnetain. Toshiaki Watanabe Ioannis Boukovinas Qian Shi Lindsay A. Renfro Donna Niedzwiecki Valter Torri Daniel J. Sargent Thierry Andre Timothy Iveson
- Networks:
- CORA, LAPS-MA036, LAPS-MN026
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80702
- Phases:
- 3
- Keywords: